5-bromo-4-chloropyrazolo[1,5-a]pyridine, 500mg

((1S,3S,4S)-3-Bromo-7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methanesulfonic acid hydrate, 98.0%, 100g

2,2-Difluoropropionic acid, 98.0%, 1g

N-(piperidin-3-yl)methanesulfonamide, 95.0%, 500mg

6-methyl-1H,4H,7H-pyrazolo[3,4-d]pyrimidin-4-one, 97%, 1g

5-[N-(tert-Butoxycarbonyl)amino]-2-chloropyridine, 97.0%, 25g

2-(2-Amino-phenoxy)-ethanol, 95.0%, 1g

3-(2-Bromo-phenyl)-propan-1-ol, 95.0%, 5g

2-(4-methylpiperazin-1-yl)-1,3-benzothiazol-6-ol, 95.0%, 500mg

1-(4-Bromo-2-nitrophenyl)piperidine, 95+%, 1g

4-Amino-2-fluorophenol, 97.0%, 10g

Methyl 3,5-dichloropicolinate, 95.0%, 100mg

Flacons individuels PCR Mμlti®, incolores, 500 µl 1000 pcs